Clinical Trial Update: Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexamethasone for relapsed or refractory acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Relapsed or Refractory Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED